STOCKHOLM & HOUSTON--(BUSINESS WIRE)--Today, Qbtech, the software provider of objective ADHD tests QbTest and QbCheck, announces an investment by specialist growth equity investor, Verdane. Qbtech is ...
HOUSTON, October 15, 2024--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced the launch of its new grant program, QbAccess. Created to make ADHD testing and care ...
STOCKHOLM--(BUSINESS WIRE)--The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment ...
Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...
A digital test that will help to provide a faster diagnosis for people with attention deficit hyperactivity disorder (ADHD) should be used by the NHS, according to draft guidance from NICE. The QbTest ...
Texas office will serve as home base for U.S. operations, expanding the company's presence in the market and contributing to the local economy Qbtech, the global leader in objective ADHD testing, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thanks to growth from an equity ...
STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create ...
Qbtech, the global leader in objective ADHD testing, today announced its one millionth patient milestone, amassing one of the most extensive data sets of patients tested for ADHD. Adopted by more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results